Prevention of ferroptosis in acute scenarios: an in vitro study with classic and novel anti-ferroptotic compounds

References

• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266–282.
   PubMed Web of Science ®Google Scholar
• Cao JY, Dixon SJ. Mechanisms of ferroptosis. Cell Mol Life Sci. 2016;73(11–12):2195–2209.
   PubMed Web of Science ®Google Scholar
• Sun L, Dong H, Zhang W, et al. Lipid peroxidation, GSH depletion, and SLC7A11 inhibition are common causes of EMT and ferroptosis in A549 cells, but different in specific mechanisms. DNA Cell Biol. 2021;40(2):172–183.
   PubMed Web of Science ®Google Scholar
• Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA. 2016;113(34):E4966–E4975.
   PubMed Web of Science ®Google Scholar
• Stoyanovsky DA, Tyurina YY, Shrivastava I, et al. Iron catalysis of lipid peroxidation in ferroptosis: regulated enzymatic or random free radical reaction? Free Radic Biol Med. 2019;133:153–161.
   PubMed Web of Science ®Google Scholar
• Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180–1191.
   PubMed Web of Science ®Google Scholar
• Jelinek A, Heyder L, Daude M, et al. Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis. Free Radic Biol Med. 2018;117:45–57. Epub 2018 Jan 31.
   PubMed Web of Science ®Google Scholar
• Conrad M, Friedmann Angeli JP. Glutathione peroxidase 4 (Gpx4) and ferroptosis: what’s so special about it? Mol cell oncol. 2015;2(3):e995047.
   PubMed Web of Science ®Google Scholar
• Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693–698.
   PubMed Web of Science ®Google Scholar
• Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6(1):41–53.
   PubMed Web of Science ®Google Scholar
• Chen D, Chu B, Yang X, et al. iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4. Nat Commun. 2021;12(1):3644.
   PubMed Web of Science ®Google Scholar
• Capelletti MM, Manceau H, Puy H, et al. Ferroptosis in liver diseases: an overview. IJMS. 2020;21(14):4908.
   Google Scholar
• Alim I, Caulfield JT, Chen Y, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell. 2019;177(5):1262.e25–1279.e25.
   Web of Science ®Google Scholar
• Mahoney-Sánchez L, Bouchaoui H, Ayton S, et al. Ferroptosis and its potential role in the physiopathology of parkinson’s disease. Prog Neurobiol. 2021;196:101890.
   PubMed Web of Science ®Google Scholar
• Reichert CO, de Freitas FA, Sampaio-Silva J, et al. Ferroptosis mechanisms involved in neurodegenerative diseases. IJMS. 2020;21(22):8765.
   Google Scholar
• Ye LF, Chaudhary KR, Zandkarimi F, et al. Radiation-Induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis Inducers. ACS Chem Biol. 2020;15(2):469–484.
   PubMed Web of Science ®Google Scholar
• Borawski B, Malyszko J. Iron, ferroptosis, and new insights for prevention in acute kidney injury. Adv Med Sci. 2020;65(2):361–370.
   PubMed Web of Science ®Google Scholar
• Kim KM, Cho SS, Ki SH. Emerging roles of ferroptosis in liver pathophysiology. Arch Pharm Res. 2020;43(10):985–996.
   PubMed Web of Science ®Google Scholar
• Kahn-Kirby AH, Amagata A, Maeder CI, et al. Targeting ferroptosis: a novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy. PLoS One. 2019;14(3):e0214250.
   PubMed Web of Science ®Google Scholar
• Skouta R, Dixon SJ, Wang J, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014;136(12):4551–4556.
   PubMed Web of Science ®Google Scholar
• Miotto G, Rossetto M, Di Paolo ML, et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 2020;28:101328.
   PubMed Web of Science ®Google Scholar
• Anthonymuthu TS, Tyurina YY, Sun WY, et al. Resolving the paradox of ferroptotic cell death: ferrostatin-1 binds to 15LOX/PEBP1 complex, suppresses generation of peroxidized ETE-PE, and protects against ferroptosis. Redox Biol. 2021;38:101744.
   PubMed Web of Science ®Google Scholar
• Hofmans S, Vanden Berghe T, Devisscher L, et al. Novel ferroptosis inhibitors with improved potency and ADME properties. J Med Chem. 2016;59(5):2041–2053.
   PubMed Web of Science ®Google Scholar
• Devisscher L, Van Coillie S, Hofmans S, et al. Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy. J Med Chem. 2018;61(22):10126–10140.
   PubMed Web of Science ®Google Scholar
• Smith WS. Pathophysiology of focal cerebral ischemia: a therapeutic perspective. J Vasc Interv Radiol. 2004;15(1):S3–S12.
   PubMedGoogle Scholar
• Albrecht P, Lewerenz J, Dittmer S, et al. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. CNS Neurol Disord Drug Targets. 2010;9(3):373–382.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Ahmed SH, Lees KR. The therapeutic time window-theoretical and practical considerations. J Stroke Cerebrovasc Dis. 2000;9(6):24–31.
   PubMedGoogle Scholar
• Neitemeier S, Jelinek A, Laino V, et al. BID links ferroptosis to mitochondrial cell death pathways. Redox Biol. 2017;12:558–570.
   PubMed Web of Science ®Google Scholar
• Farina M, Campos F, Vendrell I, et al. Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells. Toxicol Sci. 2009;112(2):416–426.
   PubMed Web of Science ®Google Scholar
• Santos DB, Peres KC, Ribeiro RP, et al. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice. Exp Neurol. 2012;233(2):767–775.
   PubMed Web of Science ®Google Scholar
• Santos DB, Colle D, Moreira ELG, et al. Probucol mitigates streptozotocin-induced cognitive and biochemical changes in mice. Neuroscience. 2015;284:590–600.
   PubMed Web of Science ®Google Scholar
• Colle D, Santos DB, Moreira EL, et al. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats. PLoS One. 2013a;8(6):e67658.
   PubMed Web of Science ®Google Scholar
• Ribeiro RP, Moreira EL, Santos DB, et al. Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson’s disease. Neurochem Res. 2013;38(3):660–668.
   PubMed Web of Science ®Google Scholar
• Troendle G, Gueriguian J, Sobel S, et al. Probucol and the QT interval. Lancet. 1982;319(8282):1179.
   Google Scholar
• Bueno DC, Canto RFS, de Souza V, et al. New probucol analogues inhibit ferroptosis, improve mitochondrial parameters, and induce glutathione peroxidase in HT22 cells. Mol Neurobiol. 2020;57(8):3273–3290.
   PubMed Web of Science ®Google Scholar
• Colle D, Santos DB, Hartwig JM, et al. Succinobucol versus probucol: higher efficiency of succinobucol in mitigating 3-NP-induced brain mitochondrial dysfunction and oxidative stress in vitro. Mitochondrion. 2013b;13(2):125–133.
   PubMed Web of Science ®Google Scholar
• Colle D, Santos DB, Hartwig JM, et al. Succinobucol, a lipid-lowering drug, protects against 3-nitropropionic acid-induced mitochondrial dysfunction and oxidative stress in SH-SY5Y cells via upregulation of glutathione levels and glutamate cysteine ligase activity. Mol Neurobiol. 2016;53(2):1280–1295.
   PubMed Web of Science ®Google Scholar
• Quispe RL, Canto RFS, Jaramillo ML, et al. Design, synthesis, and in vitro evaluation of a novel probucol derivative: protective activity in neuronal cells through GPx upregulation. Mol Neurobiol. 2018;55(10):7619–7634.
   PubMed Web of Science ®Google Scholar
• Santos DB, Colle D, Moreira EL, et al. Succinobucol, a non-statin hypocholesterolemic drug, prevents premotor symptoms and nigrostriatal neurodegeneration in an experimental model of Parkinson’s disease. Mol Neurobiol. 2017;54(2):1513–1530.
   PubMed Web of Science ®Google Scholar
• Mao SJ, Yates MT, Rechtin AE, et al. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J Med Chem. 1991;34(1):298–302.
   PubMed Web of Science ®Google Scholar
• Santos DB, Colle D, Moreira ELG, et al. Probucol protects neuronal cells against Peroxide-Induced damage and directly activates glutathione peroxidase-1. Mol Neurobiol. 2020;57(8):3245–3257.
   PubMed Web of Science ®Google Scholar
• Fellin R, Gasparotto A, Valerio G, et al. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia. Atherosclerosis. 1986;59(1):47–56.
   PubMed Web of Science ®Google Scholar
• Tardif JC, McMurray JJ, Klug E, et al. Aggressive reduction of inflammation stops events (ARISE) trial investigators. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9626):1761–1768.
   PubMed Web of Science ®Google Scholar
• Nieminen A-L, Gores GJ, Bond JM, et al. A novel cytotoxicity screening assay using a multiwell fluorescence scanner. Toxicol Appl Pharmacol. 1992;115(2):147–155.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, v. 1983;65(1–2):55–63.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77.
   PubMed Web of Science ®Google Scholar
• Cooper AJL. Role of astrocytes in maintaining cerebral glutathione homeostasis and in protecting the brain against xenobiotics and oxidative stress. In: The role of glutathione in the nervous system. Washington (DC): Taylor and Francis; 1998. p. 91–115.
   Google Scholar
• Naguib YM. A fluorometric method for measurement of peroxyl radical scavenging activities of lipophilic antioxidants. Anal Biochem. 1998;265(2):290–298.
   PubMed Web of Science ®Google Scholar
• Cos P, Hermans N, Calomme M, et al. Comparative study of eight well-known polyphenolic antioxidants. J Pharm Pharmacol. 2003;55(9):1291–1297.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193(1):265–275.
   PubMed Web of Science ®Google Scholar
• Tan S, Schubert D, Maher P. Oxytosis: a novel form of programmed cell death. Curr Top Med Chem. 2001;1(6):497–506.
   PubMedGoogle Scholar
• Drew R, Miners JO. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation. Biochem Pharmacol. 1984;33(19):2989–2994.
   PubMed Web of Science ®Google Scholar
• Franco R, Cidlowski JA. SLCO/OATP-like transport of glutathione in FasL-induced apoptosis: glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis. J Biol Chem. 2006;281(40):29542–29557.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zheng Y, Wang C, et al. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis. 2018;9(7):753.
   PubMed Web of Science ®Google Scholar
• Azouzi S, Santuz H, Morandat S, et al. Antioxidant and membrane binding properties of serotonin protect lipids from oxidation. Biophys J. 2017; 112(9):1863–1873.
   PubMed Web of Science ®Google Scholar
• Shah R, Farmer LA, Zilka O, et al. Beyond DPPH: use of fluorescence-enabled inhibited autoxidation to predict oxidative cell death rescue. Cell Chem Biol. 2019;26(11):1594–1607.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X. The chemistry and biology of ferroptosis. Cell Chem Biol. 2020; 27(4):365–375.
   PubMed Web of Science ®Google Scholar
• Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144–152.
   PubMed Web of Science ®Google Scholar
• Reich HJ, Hondal RJ. Why nature chose selenium. ACS Chem Biol. 2016;11(4):821–841.
   PubMed Web of Science ®Google Scholar
• de Bem AF, Fiuza B, Calcerrada P, et al. Protective effect of diphenyl diselenide against peroxynitrite-mediated endothelial cell death: a comparison with ebselen. Nitric Oxide. 2013 May 31;31:20–30.
   PubMed Web of Science ®Google Scholar
• Barbosa NV, Nogueira CW, Nogara PA, et al. Organoselenium compounds as mimics of selenoproteins and thiol modifier agents. Metallomics. 2017;9(12):1703–1734.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.
   PubMed Web of Science ®Google Scholar